Home › Funds › Tri Locum Partners LP › JAZZ

Tri Locum Partners LP position in JAZZ

JAZZ PHARMACEUTICALS PLC SHS USD · Health Care

Tri Locum Partners LP reported holding 221,720 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$53.4M, representing 6.57% of its reported portfolio and ranking #7 among its reported holdings. Tri Locum Partners LP has disclosed JAZZ holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)221.72K sh
Reported value held$53.43M
Portfolio Weight6.57%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tri Locum Partners LP's JAZZ position evolved

Tri Locum Partners LP first disclosed a stake in JAZZ in Q4 2024 at 161,812 shares (US$19.9M). The position peaked in Q2 2026 at 221,720 shares, worth US$53.4M. Across 3 filings, Tri Locum Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 221,720 shares valued at US$53.4M — an increase of 63,057 shares quarter over quarter.. Notable position changes include a 40% increase in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 161.81K $19.93M New
Q1 2026 158.66K $30.00M New
Q2 2026 221.72K $53.43M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 44 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has Tri Locum Partners LP held JAZZ?

Tri Locum Partners LP has disclosed JAZZ holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

What is Tri Locum Partners LP's current position in JAZZ?

As of Q2 2026, Tri Locum Partners LP holds 221.72K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $53.43M, representing 6.57% of its reported portfolio and ranking #7.

Has Tri Locum Partners LP been buying or selling JAZZ?

In the latest 13F filing (Q2 2026), Tri Locum Partners LP increased its position in JAZZ. The position peaked in Q2 2026 at 221.72K shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.